TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1 by unknown
TCT.1, a Target Molecule for -y/S T Cells, Is Encoded
by an Immunoglobulin Superfamily Gene (Blast-1)
Located in the CD1 Region of Human Chromosome 1
By Paola Del Porto, Fathia Mami-Chouaib, Jean-Michel Bruneau,"
Setsuko Jitsukawa, Jacques Dumas,* Marzia Harnois,"
and Thierry Hercend
From the Laboratoire d'Hfmato-Immunologie, INSERM, 0333, Institut Gustave-Roussy,
94805 Villejuif, France, and the 'Dipartement d'Immunologie, Roussel Udaf, 93320
Romainville, France
Summary
We have recently generated a series of y/6 T cell clones able to kill, after in vitro immunization,
an Epstein-Barr Virus-transformed B cell line (designated E418) in a non-major histocompatibility
complex-requiring fashion. A monoclonal antibody, termed anti-10113, produced against E418
was selected by its ability to block these cytotoxic interactions. Further analysis indicated that
the inhibitory effects of anti-10H3 were highly selective (i.e., no blocking activity with multiple
control clones used as effector cells; no alteration of the natural killer-like function mediated
by the relevant y/b clones against 10113+ tumor cells such as Rex). The molecule immuno-
precipitated by anti-10113, termed TCT.1, was characterized as a 43-kD protein broadly distributed
in the hematopoietic system. The TCT1 molecule has been further studied here by protein
microsequencing. Results show that the TCT1-derived peptide sequences are virtually identical
to corresponding regions ofBlast-1, a previously described surface protein with unknown function.
The likely identity of the two molecules has been strengthened by analyzing the susceptibility
of TCT.1 to phosphatidylinositol-specific phospholipase C digestion in light ofthe knownanchorage
of Blast-1 to the cell membrane through a glycosyl-phosphatidylinositol-containing lipid. The
TCT1/Blast-l-encoding gene is well characterized; it belongs to the immunoglobulin gene
superfamily and it is located in the same band of chromosome 1 as the CDl gene cluster. Together,
these data further support the view that proteins distinct from the conventional class I/II
histocompatibility molecules are involved in specific T cell recognition.
N
on-MHC-restricted cytotoxic interactions mediated by
T lymphocytes are likely to include two distinct phe-
nomena: (a) the TCRindependent recognition on target cells
of monomorphic molecules corresponding to the so-called
NK-like activity (1-7), which may well reflect the conserva-
tion by T lymphocytes of the more primitive cytotoxic func-
tions of NK cells (7, 8); and (b) the TCR-mediated specific
recognition of target molecules that are distinct from the con-
ventional MHC class I/II gene products (9-12). Although
suggested in early studies with ulo+ T lymphocytes (12),
it is only with the characterization of the y/6 receptor that
the existence of the latter phenomenon has been generally
accepted. Indeed, because class I/II molecules appear to re-
strict TCR-y/6-dependent antigen-specific T cell responses
infrequently, the search for a novel T cell recognition mecha-
nism has led several authors to propose either additional
MHC-encoded proteins (e.g., the TL [13, 14] and the Qa
antigens [15]; reviewed in reference 16) or structurally close
but MHC-independent molecules (e.g., the CD1 proteins [17,
18]) as potential TCR target structures. In this regard, we
have recently developed several y/6 alloreactive clones derived
from PBL of a healthy individual (9). Two of them, E102
and E117, generated against the E418 EBVtransformed B cell
line, were found to display a non-MHC-restricted cytotox-
icity against the immunizing E418 cells as well as a substan-
tial lytic activity against irrelevant NK target cell lines such
as K562 and Rex. The molecular characterization of the y
and 6 chain-encoding genes indicated that both clones ex-
press an infrequent TCR-y/6, associating Vy3JP2-Cy2/
V61-(D)J61-CS chains. To identify a putative target mole-
cule recognized by E102 and E117 clones, we selected, after
mice immunization with E418 cells, a mAb, anti-10113, able
to block the cytotoxic activity of both clones against E418,
while not altering the E102-E117/K562-Rex cytotoxic inter-
actions (9). Anti-10113 was found to precipitate a 43-kD mol-
ecule, designated TCT1, with a broad distribution on hema-
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these functional findings through the identification of five
additional ,y/b Tcell clones (E31,E38, E66, E69, and E116),
andcharacterizedby microsequencingthe TCT1 protein. Our
data indicate that TCT1 is most likely identical to Blast-1,
a molecule of theIg superfamily encodedin the CD1 region
of human chromosome 1 (19).
Materials and Methods
Generation ofCloned Cell Lines.
￿
E31, E38, E66, E69, andE116
y/6 CTL were generated from PBL of the same donor as E102
andE117 in a MLC usingE418 EBVtransformed B cell line as de-
scribed previously (9).
Monoclonal Antibodies.
￿
An anti-10H3mAb directed against the
TCT1 molecule wasgeneratedas described previously (9). W6/32
mAb recognizes a monomorphic determinant of the HLA class
I gene product (20). Anti-NKTa mAb recognizes an a/0 clono-
typicdeterminant (21). Anti-TryA mAb (22) directed against aVy9-
encodedepitope recognizes approximately two-thirds ofhumany/S
PBL. AntiTCR-Sl,kindly providedby M. B. Brenner (Dana-Farber
Cancer Institute, Boston,MA), reacts with aconstant determinant
ofthe TCRSchain (23). 6TCS1 mAb(24) reacts specifically with
a structure encodedby VSlJ61 gene products (25, 26). A13 and
TiV62 (27) react with V61 and V62 gene products, respectively.
BMA031, kindly provided by Dr. R. Kurrle (Behring Company,
Marburg, Germany), reacts with a monomorphic determinant of
the TCR-a/0receptor. OKT3, OKT4, and OKTS (Ortho Diag-
nostics, Raritan, NJ) react with CD3, CD4, and CD8 proteins,
respectively.
CytotoxicAssays.
￿
Thecytotoxicactivity ofthecloned cell lines
was measured by aconventional 3-h "Cr release assay using tripli-
cate cultures in Vbottomedplates.TheE/T ratiowas 10:1 on 5,000
target cells/well. Percent specific cytotoxicity was calculated con-
ventionally; standard deviations were <5%. REX (a/S T cell
leukemia) and E418 1324 (EBVtransformed B cell line, kindly
provided by Dr. J. Colombani, St. Louis Hospital, Paris) cell lines
were used as targets in cytotoxicity assays. W6/32 (anti-class I)
and1OH3 (antiTCT1) mAbs were used in functional assays. Target
cellswere preincubated for2hat 37°Cwith saturating concentra-
tion of each antibody before addition of effector cells.
Purification andAminoAcidSequence Determination of1X1 Mol-
ecule. 2 x 1010 E418 cells were lysed at 101 cells/ml in 200 ml
of X-100Ripa buffer containing 1% Triton X-100, 0.15 M NaCl,
0.5% sodium deoxycholate, 1 mM PMSF, 20 mM iodoacetamide,
and 2 Wg/ml trypsin inhibitor. Solubilized material was recovered
in the supernatant after centrifugation for 20 min at 2 x 10'g,
andeach 50-mlsample was applied to threedistinct irrelevant mAb
chromatography columns (anti-neomycin coupled to protein G) at
a flow rate of 0.1 ml/min. Therecoveredmaterial was then loaded
on an anti-IOH3/protein G 1-ml column at the same flow rate.
Thecolumns were washed sequentially with 10 ml of 20 mM Tris,
pH 8, 10% ethylene glycol,0.1% N-octylglucopyranoside, andwith
10 ml ofthesame buffer supplemented with 0.25MNaCl. Bound
material was eluted sequentially with 7.5 ml of 50 mM glycine-
-HCl (pH 2.5) and 7.5 ml of 50 mM triethylamine (pH 11) at the
flow rate of 1 ml/min. 2.5-ml fractions of each buffer were col-
lected and pooled. Samples were desalted, concentrated, and sub-
jected to electrophoresis on a10% acrylamide preparative SDS gel.
Thefragment containing theputative 43-kD molecule was cutand
electroelutedin 1 mM N-ethyl morpholyne (pH 9) using an elec-
troelution apparatus (ISCO, Inc., Lincoln, NE) (2 h at 10 mA).
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0.2 nmol was subjected to gas phase NHZ-terminal sequencing
(28), while2nmol ofelectroeluted material was digested with 2.5
,ugof endoproteinase Asp-N (Boehringer Mannheim Biochemicals)
in 100 mM Tris (pH 8.2) for 2 h at 370C. Digested material was
either separated by SDS-PAGE on a 16.5% acrylamide gel, elec-
troblotted onto polyvinylidene difluoride (29) membranes andcut
(S3), or loaded onto a 2 x 100-mm RP-300 reverse-phasecolumn
(Brownlee Labs, Inc., SantaClara, CA)installed in an 130-A high
pressure liquid chromatograph (Applied Biosystems, Inc., Foster
City, CA). The column was eluted at a flow rate of 0.15 ml/min.
The eluate was monitored at 214 nm and fractions were collected
(S14, S18, S19, S23, S24, and S116). The NHZ terminal and the
differentpeptides amino acid sequenceswere determined by sequen-
tial degradation on 470-A protein microsequencer (Applied Bio-
systems, Inc.) using modified Edman chemistry (30).
Phospholipase C Treatment of Cells.
￿
106 cells (E418, Rex, and
PHAblasts) were washed once with PLCbuffer (RPMIcontaining
2 mg/ml BSA, 10 mM Hepes, pH 7.4 and 5 x 10-1 M 2-ME),
resuspended in 1 ml of PLC, and incubated at 37°C for 60 min
with 1 Uof PI-specific PLC (Immunotech S.A., Luminy Marseille,
France) (31) or with no enzyme, as described previously (19) . The
cells were washed once with PLCbuffer followed by two washes
with PBS containing 0.5% FCS and then subjected to im-
munofluorescence analysis. Indirect immunofluorescence studies
were performedat 4°Cwith saturating concentrations ofeach mAb
and FITC-conjugated goat anti-mouse Ig serum (1).
Results and Discussion
Generation andCharacterization ofCloned Cell Lines.
￿
E31,
E38, E66, E69, and E116 were generated from PBL of the
same donor as the previously described E102 and E117 y/6
T cell clones (9). As E102 andE117, allthese clones appeared
to be CD3+, BMA031 - (TCRoi/0 -), TCR61+, =S1+,
A13+, TiV62-, TiyA-, CD4-, CD8-, and NKH1 - (data
not shown). They were also found to express a V61(D)J61-
Cb/Vy3JP2-Cy2 heterodimer, which is infrequent in human
peripheral blood (data not shown).
E31, E38, E66, E69, and E116 were assayed for cytotoxic
activity against E418-immunizing cells as well as the Rex
Table 1.
￿
Cytotoxic Activity of E31, E38, E66, E69, and E116
y/6 T Cell Clones towards E418 and Rex Target Cells
E418
Rex
Cytolytic experiments were performed either in media or in the presence
of anti-10133 or anti-W6/32 mAbs. E418- and Rex s1Cr-labeled cells
(5 x 103) were preincubated for 2 h with saturating concentration of
each antibody before the addition of effector cells (5 x 104). The indi-
catedvalues correspond to percent ofspecific lysiscalculated conventionally.
E31 E38 E66 E69 E116
Media 44 54 49 54 44
1OH3 1 3 0 5 4
W6/32 41 47 44 54 46
Media 61 46 26 71 54
1OH3 59 46 20 69 56
W6/32 61 51 26 69 60NK target cell line. As shown in Table 1, all these clones
display a strong cytotoxic activity against both the E418-
immunizing cell line and the irrelevantRex tumor cells. The
lysis of the two target cell types was not altered by the anti-
W6/32 mAb (class I specific), while anti-10H3 blocked the
cytotoxic interactions with E418 exclusively (i.e., no effect
on the TCT1+ Rex lysis). These data further support the
view that such effector T cell clones have two distinct pathways
o£ target cell recognition: non-MHC-dependent specific rec-
ognition (ofTCT.1 in the present case) and NK-like activity.
The involvement of the y/b receptor in TCT1 recognition
is not directly established; it is, however, supported by the
observation that: (a) the additional five clones described here
have the same unusual y and S rearrangements as E102 and
E117 (data not shown); and (b) the cytotoxicity of series of
randomly selected clones (CD3 -/NK, a/a+, y/b+ cells)
against a variety of TCT1+ target cells is not altered by anti-
10H3 mAb (9). Note also that the interactions ofthe TCT1-
specific y/b clones and E418 cells are inhibited by antiTCR
antibodies (thispointhas to be mentioned although it is not
conclusive because such results may reflect the transduction
of a negative signal in effector cells even when the TCR is
not involved in target cell recognition [32]).
AminoAcidSequenceIdentity of17CT1 andBlast-1.
￿
Partial
amino acid sequencing was performed to further characterize
the TCT1 molecule. A crude cell lysate from 20 x 109 E418
EBVtransformed B cells was subjected to affinity chroma-
tography with anti-101-13 mAb. After preparative gel elec-
trophoresis, the 43-kD specific material was electroeluted,
and -2.2 nmol was obtained. A fraction of the purified pro-
tein (0.2 nmol) was used in gas phase NH2-terminal se-
quencing (28), while the remaining was digested by the en-
doproteinase Asp-N, known to specifically cleave peptide bonds
NHz-terminally at aspartic acid. The degradation peptides
were either resolved by C8 reverse-phase HPLC (S14, S18,
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S19, S23, S24, and S26) or separated in SDS-PAGE prepara-
tive gel before electroblotting (29) onto polyvinylidene difluo-
ride membranes (out ofthe six peptides obtained by the latter
approach, only one, S3, couldbe sequenced unambiguously).
The NHz-terminal sequence of the whole protein (SO) and
that of seven different peptides were thus determined after
Edman degradation (30) . A computer search performed with
the PC gene program (33) revealed a high sequence homology
between SO and the corresponding region ofa previously de-
scribed surface molecule, termed Blast-1(19, 34). The whole
series of sequences (S0, S3, S14, S18, S19, S23, S24, and S26)
have thus been aligned with that of Blast-1(19, 34). As shown
in Fig. 1, the initial NHZ-terminal amino acids of TCT.1
could not be assigned with sufficient confidence. The fol-
lowing sequence (SO) is identical to Blast-1 in 20 out of the
23 characterized amino acids. Among the three differences,
two amino acid determinations were ambiguous (shown be-
tween parentheses in Fig. 1). Concerning the S3, S19, S23,
and S26 peptides, 17/21, 13/16, 15/18, and 11/12 identities
were observed, respectively, with Blast-1 peptides. In the S3
and S19 peptides, three amino acids could not be identified
(represented by an X). The sequences of S14 (six amino acids),
S18 (six amino acids), and S24 (10 amino acids) peptides were
identical to the corresponding Blast-1 fragments.
Membrane Anchorage of1L^T.1 through Glycosyl Phosphati-
dylinositol-containing Lipid. It has been previously reported
(19) that Blast-1 is anchored to the cell surface through
glycosyl-phosphatidylinositol (GPI)t-containing lipid. Phos-
pholipase C (PLC) treatment was demonstrated to specifically
release the Blast-1 protein from cell membrane with a very
unique pattern, namely totaldisappearance of the Blast-1 an-
1 Abbreviations used in this paper . GPI, glycosyl-phosphatidylinositol; PLC,
phospholipase C.
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NHz terminal (SO) and
Asp-N-derived peptide (S3, S14, S18,
S19, S23, S24, and S26) amino acid se-
quences ofTCT1 aligned with thecor-
responding sequences ofhuman Blast-1
protein (34). Ambiguous residues are
presented between parentheses. An X
indicates the residues where no assign-
ment could be made. Dots correspond
to amino acid sequence identities.
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of expression is maintained on B lymphocytes (19) . Experi-
ments were therefore performed here with TCT.1 under the
same experimental conditions reported for Blast-1 (19) . As
shown in Fig. 2, treatment of E418 cells with PI-PLC resulted
in a marked but incomplete decrease (even with increasing
enzyme concentrations) in binding of the anti-10113 mAb
assessed by immunofluorescence analysis. This decrease was
specific for TCT1 and was not observed with the control
W6/32 mAb directed against the integral transmembrane
MHC class I gene product . In contrast and consistent with
the results published by Staunton et al . (19), the treatment
of PHA-activated T cells resulted in the abrogation of anti-
10H3 binding. Similar results were also obtained with the
Rex T cell line used in the cytotoxicity assay (Fig. 2) . To-
gether, the high degree of similarity throughout the protein
sequences and the PI-PLC digestion profile strongly support
the view that the TCT.1 and Blast-1 molecules are encoded
by the same gene. Note that it has been recently suggested,
on the basis of cDNA sequence similarity, that Blast-1 is a
member of the CD48 cluster group (35) . The significance
of the partial TCT1/Blast-1 release from certain cell types
after PI-PLC digestion will have to be assessed for both struc-
tural and functional aspects in further studies.
Because TCT.1/Blast-1 is a GPI-anchored molecule, we have
tested the effect of PI-PLC treatment of E418 target cells with
respect to cytotoxicity by cloneE69 . It was found that such
treatment leads to a very strong decrease of target cell lysis
(data not shown) . These results are in line with a potential
role ofTCT1 as a ligand on target cells. However they are
not conclusive because other GPI-linked molecules, which
may be important in E/T cell interaction, such as for ex-
ample LFA-3, are removed from cell membranes after PI-PLC
treatment .
Structural and Functional Characteristics ofBlast-1 .
￿
Previous
analysis of the Blast-1 molecule showed that it belongs to
the Ig gene superfamily (19, 34) . The strongest sequence
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similarity (81% considering conservative amino acid substi-
tutions) was observed with the protein OX45 (36), which
has been proposed as Blast-1 rat homologue. Blast-1 was also
found to display a high degree ofhomology with the LFA3
molecule, particularly in the NHZ-terminal domain (61%
considering conservative amino acid substitutions) . In addi-
tion to primary sequence similarities, the three molecules
(TCT.1/Blast-1, OX45, and LFA3) share major structural
characteristics, including: (a) polypeptide length (217, 218,
and 210 amino acids, respectively) ; (b) organization in two
Ig-related domains, a distal domain of a V-SET subtype
without cysteine residues and a proximal domain of a C2
set ; (c) Winked glycosylation sites (five, five, and six, respec-
tively); and (d) GPI anchorage (19, 36, 37) . In light of these
findings, it has been suggested that Blast-1 may be involved
in nonspecific cell-cell adhesion, perhaps as an additionalCD2
ligand (19) . Our data, which provide the first observations
on TCT.1/Blast-1 functional activity, do not favor this hy-
pothesis, because its recognition appears to be limited to unique
effector cells that share a common TCR .
Cytogenetic studies have shown that the Blast-1 gene is
located in a position indistinguishable from that of the CD1
cluster at chromosome 1 q22-q23 (19) . This point is of par-
ticular interest in light of the recent results obtained with
anti-CDlc antibodies (17, 18) . Indeed, inhibition ofCDlc+
target cell lysisby y/ST cell clones using anti-CDlc reagents
has been reported with identical characteristics as those de-
scribed here (i .e., no blocking activity of anti-CD1c antibodies
with a series ofrandomly selected clones used as effector cells;
no blocking of the NK-like function) . While gene location
and functional properties of the specific antibodies tend to
suggest a related evolution of the CD1c and Blast-1/TCT1
genes, comparing the structure of the two proteins does not
provide additional elements to support this view . Indeed, the
overall degree of sequence similarity is low and the distal do-
main of CD1 is not of the Ig type (38) . In any case, our
findings strongly suggest that TCT1/Blast-1 is an additional
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Figure 2 .
￿
Immunofluorescence analysis of PI-PLC-treated or untreated E418, PHA-activated T cells, and Rex T cell line with NKTa (as negative
control) anti-10113 and antiW6/32 mAbs.molecule to be added on the increasing list (i.e., TNKtar [12];
Qa [15]; TL [13, 14, 16] ; CD1 [17, 18]; bacterial toxins [39] ;
heat shock proteins [11]; and Igs [10]) ofpotential TCR ligands
susceptible to direct specific T cell responses in a non-MHC
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